Serpil M Deger1,2,3, Adriana M Hung1,2,3, Jorge L Gamboa4, Edward D Siew1,2,3, Charles D Ellis1,3, Cindy Booker1,2,3, Feng Sha1, Haiming Li1, Aihua Bian5, Thomas G Stewart5, Roy Zent1,3, William E Mitch6, Naji N Abumrad7, T Alp Ikizler1,2,3. 1. Division of Nephrology, Vanderbilt University Medical Center (VUMC), Nashville, Tennessee, USA. 2. CSRD&D, Veterans Administration Tennessee Valley Healthcare System, Nashville, Tennessee, USA. 3. Vanderbilt Center for Kidney Disease. 4. Division of Clinical Pharmacology, and. 5. Department of Biostatistics, VUMC, Nashville, Tennessee, USA. 6. Selzman Institute for Kidney Health, Baylor College of Medicine, Department of Medicine, Houston, Texas, USA. 7. Department of Surgery, VUMC, Nashville, Tennessee, USA.
Abstract
BACKGROUND: Systemic inflammation and muscle wasting are highly prevalent and coexist in patients on maintenance hemodialysis (MHD). We aimed to determine the effects of systemic inflammation on skeletal muscle protein metabolism in MHD patients. METHODS: Whole body and skeletal muscle protein turnover were assessed by stable isotope kinetic studies. We incorporated expressions of E1, E214K, E3αI, E3αII, MuRF-1, and atrogin-1 in skeletal muscle tissue from integrin β1 gene KO CKD mice models. RESULTS: Among 129 patients with mean (± SD) age 47 ± 12 years, 74% were African American, 73% were male, and 22% had diabetes mellitus. Median high-sensitivity C-reactive protein (hs-CRP) concentration was 13 (interquartile range 0.8, 33) mg/l. There were statistically significant associations between hs-CRP and forearm skeletal muscle protein synthesis, degradation, and net forearm skeletal muscle protein balance (P < 0.001 for all). The associations remained statistically significant after adjustment for clinical and demographic confounders, as well as in sensitivity analysis, excluding patients with diabetes mellitus. In attempting to identify potential mechanisms involved in this correlation, we show increased expressions of E1, E214K, E3αI, E3αII, MuRF-1, and atrogin-1 in skeletal muscle tissue obtained from an animal model of chronic kidney disease. CONCLUSION: These data suggest that systemic inflammation is a strong and independent determinant of skeletal muscle protein homeostasis in MHD patients, providing rationale for further studies using anticytokine therapies in patients with underlying systemic inflammation. FUNDING: This study was in part supported by NIH grants R01 DK45604 and 1K24 DK62849, the Clinical Translational Science Award UL1-TR000445 from the National Center for Advancing Translational Sciences, the Veterans Administration Merit Award I01 CX000414, the SatelliteHealth Normon Coplon Extramural Grant Program, and the FDA grant 000943.
BACKGROUND:Systemic inflammation and muscle wasting are highly prevalent and coexist in patients on maintenance hemodialysis (MHD). We aimed to determine the effects of systemic inflammation on skeletal muscle protein metabolism in MHD patients. METHODS: Whole body and skeletal muscle protein turnover were assessed by stable isotope kinetic studies. We incorporated expressions of E1, E214K, E3αI, E3αII, MuRF-1, and atrogin-1 in skeletal muscle tissue from integrin β1 gene KO CKD mice models. RESULTS: Among 129 patients with mean (± SD) age 47 ± 12 years, 74% were African American, 73% were male, and 22% had diabetes mellitus. Median high-sensitivity C-reactive protein (hs-CRP) concentration was 13 (interquartile range 0.8, 33) mg/l. There were statistically significant associations between hs-CRP and forearm skeletal muscle protein synthesis, degradation, and net forearm skeletal muscle protein balance (P < 0.001 for all). The associations remained statistically significant after adjustment for clinical and demographic confounders, as well as in sensitivity analysis, excluding patients with diabetes mellitus. In attempting to identify potential mechanisms involved in this correlation, we show increased expressions of E1, E214K, E3αI, E3αII, MuRF-1, and atrogin-1 in skeletal muscle tissue obtained from an animal model of chronic kidney disease. CONCLUSION: These data suggest that systemic inflammation is a strong and independent determinant of skeletal muscle protein homeostasis in MHD patients, providing rationale for further studies using anticytokine therapies in patients with underlying systemic inflammation. FUNDING: This study was in part supported by NIH grants R01 DK45604 and 1K24 DK62849, the Clinical Translational Science Award UL1-TR000445 from the National Center for Advancing Translational Sciences, the Veterans Administration Merit Award I01 CX000414, the SatelliteHealth Normon Coplon Extramural Grant Program, and the FDA grant 000943.
Authors: Rajiv Saran; Yi Li; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; John Ayanian; Jennifer Bragg-Gresham; Rajesh Balkrishnan; Joline L T Chen; Elizabeth Cope; Paul W Eggers; Daniel Gillen; Debbie Gipson; Susan M Hailpern; Yoshio N Hall; Kevin He; William Herman; Michael Heung; Richard A Hirth; David Hutton; Steven J Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Danh V Nguyen; Ann M O'Hare; Brett Plattner; Ronald Pisoni; Friedrich K Port; Panduranga Rao; Connie M Rhee; Ankit Sakhuja; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Sarah White; Kenneth Woodside; Richard A Hirth Journal: Am J Kidney Dis Date: 2016-03 Impact factor: 8.860
Authors: G Garibotto; A Sofia; V Procopio; B Villaggio; A Tarroni; M Di Martino; V Cappelli; M T Gandolfo; F Aloisi; F De Cian; M R Sala; D Verzola Journal: Kidney Int Date: 2006-06-07 Impact factor: 10.612
Authors: Juan Jesús Carrero; Peter Stenvinkel; Lilian Cuppari; T Alp Ikizler; Kamyar Kalantar-Zadeh; George Kaysen; William E Mitch; S Russ Price; Christoph Wanner; Angela Y M Wang; Pieter ter Wee; Harold A Franch Journal: J Ren Nutr Date: 2013-03 Impact factor: 3.655
Authors: Ambra Pozzi; George Jarad; Gilbert W Moeckel; Sergio Coffa; Xi Zhang; Leslie Gewin; Vera Eremina; Billy G Hudson; Dorin-Bogdan Borza; Raymond C Harris; Lawrence B Holzman; Carrie L Phillips; Reinhard Fassler; Susan E Quaggin; Jeffrey H Miner; Roy Zent Journal: Dev Biol Date: 2008-01-31 Impact factor: 3.582
Authors: Baback Roshanravan; Leila R Zelnick; Daniel Djucovic; Haiwei Gu; Jessica A Alvarez; Thomas R Ziegler; Jorge L Gamboa; Kristina Utzschneider; Bryan Kestenbaum; Jonathan Himmelfarb; Steven E Kahn; Daniel Raftery; Ian H de Boer Journal: JCI Insight Date: 2018-08-23
Authors: Trace Thome; Zachary R Salyers; Ravi A Kumar; Dongwoo Hahn; Fabian N Berru; Leonardo F Ferreira; Salvatore T Scali; Terence E Ryan Journal: Am J Physiol Cell Physiol Date: 2019-07-10 Impact factor: 4.249
Authors: Matthew K Abramowitz; William Paredes; Kehao Zhang; Camille R Brightwell; Julia N Newsom; Hyok-Joon Kwon; Matthew Custodio; Rupinder S Buttar; Hina Farooq; Bushra Zaidi; Rima Pai; Jeffrey E Pessin; Meredith Hawkins; Christopher S Fry Journal: Am J Physiol Renal Physiol Date: 2018-10-03
Authors: Geraldo José de Amorim; Cinthia Katiane Martins Calado; Bruno Carlos Souza de Oliveira; Renata Patricia Oliveira Araujo; Tayrine Ordonio Filgueira; Matheus Santos de Sousa Fernandes; Angela Castoldi; Gisele Vajgel; Lucila Maria Valente; José Luiz de Lima-Filho; Paulo Roberto Cavalcanti Carvalho; Fabricio Oliveira Souto Journal: Front Med (Lausanne) Date: 2022-04-07
Authors: Stephan van Vliet; Sarah K Skinner; Joseph W Beals; Brandon A Pagni; Hsin-Yu Fang; Alexander V Ulanov; Zhong Li; Scott A Paluska; Michael Mazzulla; Daniel W D West; Daniel R Moore; Kenneth R Wilund; Nicholas A Burd Journal: Kidney Int Rep Date: 2018-08-17